Back to News
Market Impact: 0.2
Biotech Stocks At 52-Week Highs - OABI +13%, FRNM, EXEL, FTH, LFST
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Biotech stocks hit new 52-week highs on Sept. 2, 2026, as investors responded to new regulatory milestones and/or positive financial updates, signaling incremental momentum for the group despite a lack of specific deal or earnings figures in the report.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Nvidia in talks to invest up to $10 billion in Anthropic IPO
- The inside story on the historic U.S.-Venezuela oil deal and how it will work
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Surging cloud revenue boosted Oracle’s quarterly results. Here’s what analysts are saying
- Exclusive-Nvidia in talks to invest in Anthropic’s mega IPO, sources say
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports